Dave Keane
Dave Keane has worked in the Genetics testing field since 1998. He became interested in Mitochondrial Disease in 2004 and has attended almost 20 UMDF symposia. His career has taken him from Athena Diagnostics, Transgenomic, GeneDx and now Variantyx. He has attended approximately 50 Mito grand rounds presented by Bruce Cohen, Sumit Parikh, Fran Kendall, Bob Naviaux, Amy Goldstein and others. He works closely with the UMDF and MitoAction to facilitate genetic testing for hundreds of Mito patients and has always functioned from a “the patient comes first” perspective.
Gene Kelly
Gene Kelly joined Stealth BioTherapeutics in 2014 and is currently the Executive Director of Medical Affairs. He has broad experience in pre-commercialization activities and has held leadership roles at both public and private biotechnology companies. Gene has worked closely with Mitochondrial Medicine Experts and Rare Disease Patient Advocacy Groups to gain insights that guide clinical development and disease awareness programs. He holds a bachelor’s degree in Pharmacy.